Newly launched US drugs head toward record high prices in 2022

Reuters

15 August 2022 - Drugmakers are launching new medicines at record high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to cut the $500 billion plus annual bill for prescription drugs in the US.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Affordability